Atlas Trials

Expanded Access for CC-486

Clinical trial NCT03723135 · APPROVED_FOR_MARKETING

Trial details

NCT number
NCT03723135
Sponsor
Celgene
Status
APPROVED_FOR_MARKETING
Study type
EXPANDED_ACCESS
Acute Myelogenous Leukemia (AML)

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.